Quarterly report · Q1
2590.TEDINET S100QVFN
Period2023-01-21 → 2023-04-20
Filed2023-06-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.1bn | 2023-01-21 → 2023-04-20 | Cons. | Net sales |
| Revenue | ¥160.1bn | 2022-01-21 → 2023-01-20 | Cons. | Net sales (5-year summary) |
| Revenue | ¥34.9bn | 2022-01-21 → 2022-04-20 | Cons. | Net sales |
| Operating income | −¥539m | 2023-01-21 → 2023-04-20 | Cons. | Operating income |
| Operating income | −¥986m | 2022-01-21 → 2022-04-20 | Cons. | Operating income |
| Ordinary income | −¥442m | 2023-01-21 → 2023-04-20 | Cons. | Ordinary income |
| Ordinary income | ¥591m | 2022-01-21 → 2023-01-20 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2022-01-21 → 2022-04-20 | Cons. | Ordinary income |
| Profit before tax | −¥87m | 2023-01-21 → 2023-04-20 | Cons. | Income before income taxes |
| Profit before tax | −¥1.2bn | 2022-01-21 → 2022-04-20 | Cons. | Income before income taxes |
| Net income (owners) | −¥296m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥507m | 2022-01-21 → 2023-01-20 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥1.6bn | 2022-01-21 → 2022-04-20 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥299m | 2023-01-21 → 2023-04-20 | Cons. | Profit loss |
| Net income | −¥1.6bn | 2022-01-21 → 2022-04-20 | Cons. | Profit loss |
| Total assets | ¥179.1bn | at 2023-04-20 | Cons. | Assets |
| Total assets | ¥164.2bn | at 2023-01-20 | Cons. | Assets |
| Total assets | ¥165.3bn | at 2022-04-20 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥90.6bn | at 2023-04-20 | Cons. | Liabilities |
| Total liabilities | ¥80.1bn | at 2023-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥88.5bn | at 2023-04-20 | Cons. | Net assets |
| Net assets / equity | ¥84.1bn | at 2023-01-20 | Cons. | Net assets |
| Net assets / equity | ¥83.0bn | at 2022-04-20 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.2bn | at 2023-04-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.2bn | at 2023-01-20 | Cons. | Cash and deposits |
| EPS (basic) | ¥-18.9 | 2023-01-21 → 2023-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.4 | 2022-01-21 → 2023-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-99.09 | 2022-01-21 → 2022-04-20 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 48.4% | at 2023-04-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2023-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.9% | at 2022-04-20 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2023-04-20 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2023-04-20 | −¥151m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥34.7bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥238m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥133m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥4.1bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥5.3bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | −¥84m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2023-04-20 | ¥3.0bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥63m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2023-04-20 | ¥34m |
| —segment total | revenue | 2023-01-21 → 2023-04-20 | ¥47.2bn |
| —segment total | revenue external | 2023-01-21 → 2023-04-20 | ¥47.1bn |
| —segment total | revenue intersegment | 2023-01-21 → 2023-04-20 | ¥77m |
| —segment total | segment profit | 2023-01-21 → 2023-04-20 | −¥387m |
| Reconciling Itemsreconciling | revenue | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-21 → 2022-04-20 | −¥134m |
| Reconciling Itemsreconciling | segment profit | 2022-01-21 → 2022-04-20 | −¥270m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥24.8bn |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥12m |
| jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥325m |
| jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥96m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥4.3bn |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥1m |
| jpcrp040300-q1r_E00424-000Food Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | ¥234m |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥3.1bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥3.1bn |
| jpcrp040300-q1r_E00424-000International Beverage Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥499m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue | 2022-01-21 → 2022-04-20 | ¥2.9bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue external | 2022-01-21 → 2022-04-20 | ¥2.7bn |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥120m |
| jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segment | segment profit | 2022-01-21 → 2022-04-20 | −¥28m |
| —segment total | revenue | 2022-01-21 → 2022-04-20 | ¥35.0bn |
| —segment total | revenue external | 2022-01-21 → 2022-04-20 | ¥34.9bn |
| —segment total | revenue intersegment | 2022-01-21 → 2022-04-20 | ¥134m |
| —segment total | segment profit | 2022-01-21 → 2022-04-20 | −¥715m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 393
| Item | Context | Value | Unit |
|---|---|---|---|
| Assets | CurrentQuarterInstant | 179107000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 20823000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 26118000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 3812000000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 4178000000 | JPY |
| Accounts payable other | Prior1YearInstant | 12300000000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 12253000000 | JPY |
| Income taxes payable | Prior1YearInstant | 888000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 820000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1237000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 2356000000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | － | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 7000000 | JPY |
| Other cl | Prior1YearInstant | 4212000000 | JPY |
| Other cl | CurrentQuarterInstant | 4647000000 | JPY |
| Current liabilities | Prior1YearInstant | 43275000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 50383000000 | JPY |
| Bonds payable | Prior1YearInstant | 20000000000 | JPY |
| Bonds payable | CurrentQuarterInstant | 20000000000 | JPY |
| Long term loans payable | Prior1YearInstant | 7675000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 8763000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 174000000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 11000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | Prior1YearInstant | 164000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | CurrentQuarterInstant | 133000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 346000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 1847000000 | JPY |
| Other ncl | Prior1YearInstant | 8500000000 | JPY |
| Other ncl | CurrentQuarterInstant | 9469000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 36861000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 40225000000 | JPY |
| Liabilities | Prior1YearInstant | 80137000000 | JPY |
| Liabilities | CurrentQuarterInstant | 90609000000 | JPY |
| Capital stock | Prior1YearInstant | 1924000000 | JPY |
| Capital stock | CurrentQuarterInstant | 1924000000 | JPY |
| Capital surplus | Prior1YearInstant | 374000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 1832000000 | JPY |
| Retained earnings | Prior1YearInstant | 86717000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 85944000000 | JPY |
| Treasury stock | Prior1YearInstant | -4048000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -3998000000 | JPY |
| Shareholders equity | Prior1YearInstant | 84967000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 85702000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 5846000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 7806000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 1043000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | 923000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -8076000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | -7451000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -190000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |